By using data and statistics, we strengthen the cluster’s appeal and guide strategic decisions. With five top universities, world-leading hospitals, recognized authorities, and a dynamic business community with over half of Sweden’s life science sector concentrated here, the cluster offers a strong foundation for innovation and global collaboration.

Karolinska Institutet (KI), in collaboration with the pharmaceutical company Chiesi, is working closely to develop new opportunities for research aimed at advancing knowledge and treatment in respiratory diseases, rare diseases, and neonatology.

Jan Ellenberg has been the Director of SciLifeLab since July. In this interview, he shares his views of what he believes will be contributary for SciLifeLab. He also reflects on the strengths and challenges facing the Swedish life science industry.

The overall goal for Public & Science Sweden (Vetenskap & Allmänhet) is to make science accessible to everyone. This non-profit, national expert and membership organization has worked to promote dialogue and openness between researchers and the public for over 20 years.